Biosig Technologies Price to Book Ratio 2012-2024 | BSGM
Historical price to book ratio values for Biosig Technologies (BSGM) over the last 10 years. The current price to book ratio for Biosig Technologies as of May 02, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Biosig Technologies Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-01 | 1.22 | 0.00 | |
| 2024-12-31 | 1.49 | $-0.09 | -16.82 |
| 2024-09-30 | 0.34 | $-0.02 | -14.59 |
| 2024-06-30 | 0.35 | $0.00 | 500.14 |
| 2024-03-31 | 0.66 | $-0.39 | -1.71 |
| 2023-12-31 | 4.75 | $-0.33 | -14.35 |
| 2023-09-30 | 4.89 | $-0.13 | -36.76 |
| 2023-06-30 | 12.50 | $0.05 | 277.16 |
| 2023-03-31 | 11.40 | $0.29 | 39.90 |
| 2022-12-31 | 4.20 | $0.05 | 79.25 |
| 2022-09-30 | 6.40 | $0.40 | 15.98 |
| 2022-06-30 | 6.58 | $1.56 | 4.23 |
| 2022-03-31 | 11.50 | $2.38 | 4.83 |
| 2021-12-31 | 22.30 | $3.50 | 6.37 |
| 2021-09-30 | 29.80 | $5.27 | 5.66 |
| 2021-06-30 | 38.60 | $4.51 | 8.56 |
| 2021-03-31 | 43.10 | $6.37 | 6.77 |
| 2020-12-31 | 39.00 | $8.18 | 4.77 |
| 2020-09-30 | 49.30 | $9.92 | 4.97 |
| 2020-06-30 | 72.00 | $12.36 | 5.82 |
| 2020-03-31 | 41.90 | $6.09 | 6.88 |
| 2019-12-31 | 59.20 | $5.00 | 11.84 |
| 2019-09-30 | 82.50 | $5.64 | 14.64 |
| 2019-06-30 | 93.90 | $4.71 | 19.93 |
| 2019-03-31 | 61.40 | $5.09 | 12.05 |
| 2018-12-31 | 42.70 | $1.97 | 21.67 |
| 2018-09-30 | 55.80 | $4.01 | 13.91 |
| 2018-06-30 | 59.25 | $2.10 | 28.27 |
| 2018-03-31 | 39.25 | $-0.48 | -81.11 |
| 2017-12-31 | 36.00 | $-2.77 | -12.99 |
| 2017-09-30 | 34.00 | $-4.53 | -7.51 |
| 2017-06-30 | 36.75 | $-4.07 | -9.03 |
| 2017-03-31 | 36.25 | $-3.26 | -11.13 |
| 2016-12-31 | 32.25 | $-3.08 | -10.45 |
| 2016-09-30 | 38.00 | $-4.94 | -7.69 |
| 2016-06-30 | 38.25 | $-4.17 | -9.17 |
| 2016-03-31 | 35.00 | $-5.71 | -6.13 |
| 2015-12-31 | 32.38 | $-4.32 | -7.49 |
| 2015-09-30 | 35.00 | $-6.65 | -5.26 |
| 2015-06-30 | 57.50 | $-10.96 | -5.24 |
| 2015-03-31 | 60.00 | $-13.24 | -4.53 |
| 2014-12-31 | 70.00 | $-8.01 | -8.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.033B | $0.000B |
| BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The Company's first product, PURE EP (tm) System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. | |||